Related references
Note: Only part of the references are listed.Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients
Rita Indirli et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)
Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx
Heidi N. du Preez et al.
FASEB JOURNAL (2022)
Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19
J. Torres-Torres et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2022)
SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19
Abaher O. Al-Tamimi et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2022)
Plasma Total Antioxidant Capacity and Carbonylated Proteins Are Increased in Pregnant Women with Severe COVID-19
Juan Mario Solis-Paredes et al.
VIRUSES-BASEL (2022)
Relationship Between Endothelial and Angiogenesis Biomarkers Envisage Mortality in a Prospective Cohort of COVID-19 Patients Requiring Respiratory Support
Felipe Maldonado et al.
FRONTIERS IN MEDICINE (2022)
Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study
Abdisa Tufa et al.
FRONTIERS IN IMMUNOLOGY (2022)
Plasma Endothelial and Oxidative Stress Biomarkers Associated with Late Mortality in Hospitalized COVID-19 Patients
Arturo Orea-Tejada et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Von Willebrand Factor and ADAMTS-13 Are Associated with the Severity of COVID-19 Disease
Nataliya Dolgushina et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
Geir Hetland et al.
VACCINES (2022)
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients
Marina Marchetti et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Circulating Syndecan-1 as a Predictor of Persistent Thrombocytopenia and Lethal Outcome: A Population Study of Patients With Suspected Sepsis Requiring Intensive Care
Kosaku Hatanaka et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays
Danielle White et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
Plasma P-selectin is an early marker of thromboembolism in COVID-19
Bank G. Fenyves et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Complement activation and endothelial perturbation parallel COVID-19 severity and activity
Massimo Cugno et al.
JOURNAL OF AUTOIMMUNITY (2021)
The ADAMTS13-von Willebrand factor axis in COVID-19 patients
Ilaria Mancini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure
Gianluca Campo et al.
PLATELETS (2021)
Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients
Luis Garcia de Guadiana-Romualdo et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
Alice G. Vassiliou et al.
CELLS (2021)
An immune-based biomarker signature is associated with mortality in COVID-19 patients
Michael S. Abers et al.
JCI INSIGHT (2021)
MR-proADM as marker of endotheliitis predicts COVID-19 severity
Luis Garcia de Guadiana-Romualdo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients
Mario Rodriguez Rodriguez et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
Role of Cell Adhesion Molecules for Prognosis of Disease Development of Patients With and Without COVID-19 in the Emergency Department
Wolfgang Bauer et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
Giorgia Montrucchio et al.
PLOS ONE (2021)
ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19
Tiffany Pascreau et al.
THROMBOSIS RESEARCH (2021)
Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19
Salvador Espino-Y-Sosa et al.
VIRUSES-BASEL (2021)
Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study
Crhistian-Mario Oblitas et al.
VIRUSES-BASEL (2021)
Glycocalyx as Possible Limiting Factor in COVID-19
Patricia P. Wadowski et al.
FRONTIERS IN IMMUNOLOGY (2021)
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19
Erica Villa et al.
BLOOD ADVANCES (2021)
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality
David M. Smadja et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Biomarkers Associated with Failure of Liberation from Oxygen Therapy in Severe COVID-19: A Pilot Study
Oh Joo Kweon et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19)
Sajad Karampoor et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort study
Jos A. H. van Oers et al.
JOURNAL OF CRITICAL CARE (2021)
The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study
Handan Alay et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients
Berangere S. Joly et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study
Emre Karsli et al.
LIFE SCIENCES (2021)
Role of Serum E-Selectin as a Biomarker of Infection Severity in Coronavirus Disease 2019
Alessandra Oliva et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Further Findings Concerning Endothelial Damage in COVID-19 Patients
Monica Gelzo et al.
BIOMOLECULES (2021)
Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection
Ivo M. B. Francischetti et al.
ECLINICALMEDICINE (2021)
Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis
Golzar Mobayen et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)
Predictive Role of Haematological Determinants on Outcomes of Critically Ill COVID-19 Patients Admitted to Intensive Care Unit
Ahilanandan Dushianthan et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection
Sandra Lopez-Castaneda et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2021)
Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality
Fien A. von Meijenfeldt et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Christophe Nougier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID-19
Christophe Guervilly et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19
Minako Yamaoka-Tojo
BIOMEDICAL JOURNAL (2020)
Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome
Marco Ranucci et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Circulating markers of angiogenesis and endotheliopathy in COVID-19
Matthew L. Meizlish et al.
PULMONARY CIRCULATION (2020)
Mending Leaky Blood Vessels: The Angiopoietin-Tie2 Pathway in Sepsis
Sascha David et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?
Patrick Paulus et al.
BIOMARKERS (2011)
Mechanical ventilation with high tidal volume induces inflammation in patients without lung disease
Roselaine Pinheiro de Oliveira et al.
CRITICAL CARE (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)